After nine months in the womb, humans enter a world filled with texture and shape. We must then quickly learn to recognize ...

Salk neuroscientists discover brain area called gracile nucleus is central to the development of mechanical allodynia, a ...

A single psilocybin dose relieved chronic pain and depression-like symptoms in mice by rebalancing brain circuits that regulate mood and pain.

Complex Regional Pain Syndrome (CRPS), a neurological disorder affecting the central and peripheral nervous systems, manifests with intense pain, skin ...

Study findings could inform therapies for other conditions involving dysregulated brain circuits, such as addiction or PTSD.

BTIG initiated coverage on Bright Minds Biosciences Inc. (NASDAQ:DRUG), a clinical-stage company focused on neurological and psychiatric disorders. Investment in Bright Minds is based on the ...

New research shows that psilocybin, the active compound in psychedelic mushrooms, can reduce both chronic pain and pain-related depression by modulating brain circuits rather than acting at the site ...

Diabetes is one of the most common conditions in the world and is associated with a broad range of adverse effects in multiple organ systems. Roughly half of all patients with diabetes will develop a ...

Researchers have identified specific brain circuits that are impacted by psilocybin, the active compound found in some ...

Penn Medicine researchers discovered that psilocybin can ease chronic pain and depression by subtly tuning serotonin activity in the brain.

A new clinical perspective proposes a diagnostic algorithm for dyspareunia based on pain mechanisms. Learn how to use this framework to improve diagnostic accuracy and tailor treatments.